Lumina Fund Management’s Pfizer PFE Stock Holding History

Lumina Fund Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-30,000	Closed	-$995K	–	37
2023 Q3	$995K	Hold	30,000	–	–	0.34%	22
2023 Q2	$1.1M	Hold	30,000	–	–	0.47%	20
2023 Q1	$1.22M	Hold	30,000	–	–	0.58%	12
2022 Q4	$1.54M	Hold	30,000	–	–	0.58%	10
2022 Q3	$1.31M	Hold	30,000	–	–	0.5%	8
2022 Q2	$1.57M	Hold	30,000	–	–	0.59%	9
2022 Q1	$1.55M	Hold	30,000	–	–	0.49%	10
2021 Q4	$1.77M	Hold	30,000	–	–	0.55%	11
2021 Q3	$1.29M	Hold	30,000	–	–	0.46%	12
2021 Q2	$1.18M	Hold	30,000	–	–	0.54%	14
2021 Q1	$1.09M	Hold	30,000	–	–	0.41%	14
2020 Q4	$1.1M	Sell	30,000 -1,620	-5%	-$59.4K	0.46%	15
2020 Q3	$1.1M	Hold	31,620	–	–	0.67%	12
2020 Q2	$981K	Buy	31,620 +30,039	+1,900%	+$1.02M	0.57%	13
2020 Q1	$49K	Buy	+1,581	New	+$53.9K	0.03%	35

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lumina Fund Management's PFE Position: Q4 2023 in Review

Lumina Fund Management sold out of Pfizer (PFE) in Q4 2023, closing a stake of 30,000 shares — an estimated $995K sold.

Lumina Fund Management first reported a position in PFE in Q1 2020 and held it in 15 quarters. The position peaked at $1.77M in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Lumina Fund Management reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Lumina Fund Management sold 30,000 Pfizer shares in Q4 2023, an estimated $995K.
Lumina Fund Management first reported a position in Pfizer in Q1 2020 and held it in 15 quarters.
Lumina Fund Management's Pfizer position peaked at $1.77M in Q4 2021.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Lumina Fund Management's 13F filing for Q4 2023, filed 2 Feb 2024.